Researchers at the Broad Institute are leading an investigation to determine how Crohn’s disease develops and identify potential therapies. In the U.S., 201 of every 100,000 individuals suffer from Crohn’s disease, a chronic inflammatory bowel disease that causes symptoms like persistent diarrhea,... Read More
The West imports plenty of goods from Asia. But there’s one transfer in the other direction that is very negative indeed. It’s the job of gastroenterologist Siew Ng at the Chinese University of Hong Kong (CUHK) to stop that flow. Two decades ago, inflammatory bowel disease (IBD) was virtually... Read More
Dr. Jean-Frederic Colombel is director of The Leona M. and Harry B. Helmsley Charitable Trust Inflammatory Bowel Disease Center at Mount Sinai Hospital where he oversees research aimed at advancing the understanding of IBD and developing effective treatments for the estimated 1.4 million people in... Read More
Bringing together the best and brightest, the Broad Institute marshals its shared experience to develop the next generation of safe and effective therapies for Crohn's disease. Science has well established that genes play a chief role in the development and progression of certain diseases. But... Read More
Helmsley and the Crohn's & Colitis Foundation of America work together to unlock the secrets of the human microbiome. Within every human body, trillions of microorganisms, viruses and bacterial cells – both good and bad –influence the state of our health and illnesses. This vast community of... Read More